Differences Among Angiotensin II Type 1 Receptor Blockers: Characteristics of Candesartan Cilexetil

ISSN： 0803-7051

Source： Blood Pressure, Vol.9, Iss.1, 2000-05, pp. : 14-18

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Candesartan Cilexetil, a Novel Angiotensin II Type 1 (AT1) Receptor Blocker, Reduces Microalbuminuria in Patients with Type II Diabetes Mellitus and Mild Hypertension

By TRENKWALDER P. DAHL K. LEHTOVIRTA M. MULDER H.

Blood Pressure, Vol. 9, Iss. 1, 2000-05 ,pp. : 57-57

Informa Healthcare

Access to resources Recommend Favorite

TRANSCEND Aftermath: Angiotensin II Type 1 Receptor Antagonists (Angiotensin Receptor Blockers) at the Clinical Crossroad

By Volpe Massimo

High Blood Pressure & Cardiovascular Prevention, Vol. 16, Iss. 1, 2009-05 ,pp. : 1-6

Adis International

Access to resources Recommend Favorite

By Alberto Corsini

High Blood Pressure & Cardiovascular Prevention, Vol. 11, Iss. 3, 2004-01 ,pp. : 117-121

Adis International

Access to resources Recommend Favorite

Is it Possible to Differentiate between Angiotensin II Type 1 (AT1) Receptor Blockers in Normotensive Volunteers?

By AZIZI M. NICOLET L. CHATELLIER G. GUYENE T. T. HEMPENIUS J. MÉNARD J.

Blood Pressure, Vol. 9, Iss. 1, 2000-05 ,pp. : 53-53

Informa Healthcare

Access to resources Recommend Favorite

Prescription Data Related to the Use of Calcium Channel Blockers, ACE Inhibitors and Angiotensin II Type 1 Receptor Antagonists (Angiotensin Receptor Blockers) in Combination Identify Savings Opportunities

By Carugo Stefano

High Blood Pressure & Cardiovascular Prevention, Vol. 16, Iss. 1, 2009-05 ,pp. : 21-26

Adis International

Access to resources Recommend Favorite